This site is intended for healthcare professionals only
LoginRegister
CDSCO Panel Declines to Consider ACME Generics Phase IV Trial Results for Liothyronine TabletsZiller Medical Denied Manufacturing Nod for Cervical Cerclage Pessary Over Inadequate Safety Data
CDSCO Panel Asks Shilpa Biologicals to Revise Phase III Protocol for Recombinant Human Serum Albumin StudyCDSCO Panel Asks Shilpa Biologicals to Revise Phase III Protocol for Recombinant Human Serum Albumin...
Banned in Himachal, YL Pharma Under Rajasthan Scanner After Spurious Drug DetectionBanned in Himachal, YL Pharma Under Rajasthan Scanner After Spurious Drug Detection
Zydus-Owned Sentynl Gets USFDA Nod for First-Ever Menkes Disease Treatment ZYCUBOZydus bags tentative USFDA nod for Crohn's disease drug Budesonide delayed release
Gland Pharma profit rises 12 percent to Rs 184 crore in Q2Gland Pharma profit rises 12 percent to Rs 184 crore in Q2
Bharat Biotech unveils Cell and Gene Therapy CRDMO - NucelionBharat Biotech unveils Cell and Gene Therapy CRDMO - Nucelion
USFDA drug division chief George Tidmarsh resignsUSFDA drug division chief George Tidmarsh resigns
Pfizer files second lawsuit against Metsera, its controlling stockholders, Novo NordiskPfizer files second lawsuit against Metsera, its controlling stockholders, Novo Nordisk
Eli Lilly Donanemab secures CDSCO nod for early symptomatic Alzheimers DiseaseEli Lilly plans to build new USD 3 billion facility in Netherlands
Low-Risk Medical Device Makers Get Clarity: CDSCO Publishes Class A Risk Classification List under MDR 2017Low-Risk Medical Device Makers Get Clarity: CDSCO Publishes Class A Risk Classification List under...
AstraZeneca Gets SEC Nod to Update Lokelma Prescribing Information for Hyperkalemia TreatmentAstraZeneca Gets SEC Nod to Update Lokelma Prescribing Information for Hyperkalemia Treatment
CDSCO Expert Panel Backs Akums Faropenem Dispersible Tablets, Grants CT, BE WaiversAkums Wins 20-Year Patent for Dual Release PPI, Promises Long-Lasting GERD Relief
X